Everything tagged "nyse" across the TickerSpark archives.
Devonian Health Group Inc. (NYSE: DHGR) is expected to list on 2026-08-21, but the company has not disclosed a price range yet. The setup is a clinical-stage biotech story with a commercial distribution business behind it, which gives it a real revenue base but also a financing-heavy path ahead.
Petrolia Energy Corporation is expected to list on the NYSE on 2026-08-20, but the price range has not been disclosed and shares offered are still undisclosed. The setup is unusual: the company appears to be an existing OTC-traded issuer, not a fresh IPO story, so shareholders should watch for whether this is a true re-listing or just a calendar placeholder.
Northern Lights Fund Trust III is expected to list on the NYSE on 2026-08-14, but the price range has not been disclosed. The filing set does not show a traditional operating-company IPO; it points to an existing Delaware statutory trust used to launch and administer funds. Watch whether investors treat this as a fund-platform story or pass until there is clearer pricing and a specific series-level catalyst.
Lyntris Inc. (NYSE: LYNX) is expected to list on 2026-08-19 at a price range of $19.00 to $22.00 per share. The company is offering 24,000,000 shares, with a disclosed market cap of $607,200,000 if priced at the top of the range. The bull case is a defense-tech platform built around sensing, AI-driven data fusion, and mission systems; the bear case is that key IPO financials and filing details have not been publicly disclosed in the sources found.
CSRA Inc. is listed as expected to debut on the NYSE on 2026-08-12, but the price range has not been disclosed. The key issue is that the company’s SEC filings show CSRA already filed an S-1 in 2015 and was later acquired in 2018, so investors should watch this calendar entry closely for accuracy before treating it like a fresh IPO.
Guinness Atkinson Funds is expected to list on the NYSE on 2026-08-12, but the price range has not been disclosed. The bigger question is whether this is really an IPO at all, or a routine SEC fund filing for an existing investment company. Bull case: ETF-class expansion in a regulated fund family. Bear case: no IPO economics, no pricing, and no operating-company growth story.
Valued Advisers Trust is expected to list on 2026-08-12 on the NYSE, but the price range has not been disclosed. The key issue is that the SEC materials reviewed do not show a traditional operating-company IPO; they describe a long-running registered investment company platform instead. That makes this a watch-the-structure story more than a standard growth IPO.
ARIAD Pharmaceuticals, Inc. (NYSE: ARIA) is expected to list on 2026-08-10, but the price range has not been disclosed. The key question is not valuation yet—it is whether this is a real upcoming IPO filing or a historical company reference that still needs confirmation. Bull case: a recognizable biotech name; bear case: the current offering details are not yet verified.
SunScout Holding Limited (NYSE: SNSC) is expected to list on 2026-08-07, with shares offered and price range not yet disclosed. The company is a New Zealand-based solar-powered mower and solar solutions business that is still early in its public-market story. Bull case: a niche robotics-and-solar angle; bear case: limited disclosure, small cash balance, and an early-stage structure.
First Trust Exchange-Traded Fund VIII (FFLX) is expected to list on NYSE on 2026-08-10, but the price range has not been disclosed. This looks less like a classic IPO and more like an ETF trust listing with creation/redemption mechanics. Watch whether the fund’s product lineup and fee structure can attract assets in a crowded ETF market.
Carillon Series Trust is expected to list on 2026-08-03 on the NYSE, but the price range has not been disclosed. The key question is not a classic IPO valuation debate — it is whether this fund platform’s ETF conversion story is compelling enough to attract attention. Bull case: the structure taps the ongoing shift from mutual funds to ETFs. Bear case: this is not a traditional operating-company IPO, so the usual growth and profitability metrics are not available.
Arm Holdings plc is expected to list on the NYSE on 2026-07-30, but the price range has not been disclosed. The company’s business is built on licensing CPU architecture and collecting royalties, with a huge ecosystem behind it. Watch whether investors focus on its 97.5% gross margin profile or the heavy customer concentration and China exposure.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime